Work

A phase I study of R547, a novel, selective inhibitor of cell cycle and transcriptional cyclin dependent kinases (CDKs)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3528

Authors: S. Diab, S. Eckhardt, A. Tan, G. Frenette, L. Gore, W. Depinto, J. Grippo, M. DeMario, S. Mikulski, S. Papadimitrakopoulou

Institutions: University of Colorado Health, Rutgers Cancer Institute

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1930147619

Cites:

Cited by: 29

Related to: 10